Exome Asset Management’s Celcuity CELC Stock Holding History

Exome Asset Management’s Portfolio CELC Stock Details CELC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,289	Closed	-$3.42M	–	60
2025 Q4	$3.42M	Buy	+34,289	New	+$2.82M	1.64%	22

Other funds holding CELC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exome Asset Management's CELC Position: Q1 2026 in Review

Exome Asset Management sold out of Celcuity (CELC) in Q1 2026, closing a stake of 34,289 shares — an estimated $3.42M sold.

Exome Asset Management first reported a position in CELC in Q4 2025 and held it in 1 quarter. The position peaked at $3.42M in Q4 2025. 276 funds tracked by Wall St. Rank hold CELC as of Q1 2026.

Exome Asset Management reported no remaining Celcuity position as of Q1 2026 after selling out during the quarter.
Exome Asset Management sold 34,289 Celcuity shares in Q1 2026, an estimated $3.42M.
Exome Asset Management first reported a position in Celcuity in Q4 2025 and held it in 1 quarter.
Exome Asset Management's Celcuity position peaked at $3.42M in Q4 2025.
276 funds tracked by Wall St. Rank held Celcuity as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.